Shares of Check Cap Ltd (NASDAQ:CHEK) gapped up before the market opened on Tuesday . The stock had previously closed at $2.01, but opened at $2.02. Check Cap shares last traded at $2.07, with a volume of 152,837 shares.

CHEK has been the topic of several research analyst reports. Maxim Group reaffirmed a “buy” rating on shares of Check Cap in a research note on Thursday, May 19th. Chardan Capital dropped their price objective on Check Cap from $6.00 to $4.00 and set a “buy” rating on the stock in a research note on Friday, May 20th. Finally, Zacks Investment Research raised Check Cap from a “hold” rating to a “buy” rating and set a $1.50 price objective on the stock in a research note on Tuesday, June 14th.

The stock’s 50 day moving average is $1.71 and its 200-day moving average is $2.22. The stock’s market cap is $25.00 million.

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.